Benralizumab Reduces Need for Inhaled Steroids for Severe Asthma
Findings from a multinational study demonstrated that 92% of patients using benralizumab could safely reduce inhaled steroid dose, and more than 60% could stop all use.
Findings from a multinational study demonstrated that 92% of patients using benralizumab could safely reduce inhaled steroid dose, and more than 60% could stop all use.
Though previous studies have shown that SARS-CoV-2 can directly infect tissues such as the lungs and brain, less was known about its effect on the coronary arteries.
The AI-powered chest X-ray triage solution was designed to triage and prioritize emergency cases such as pleural effusion and pneumothorax immediately after the exam.
A clinical trial has shown that patients with chronic rhinitis experienced sustained symptom relief and improved quality of life for up to two years following treatment.
ResMed has issued an urgent field safety notice for its CPAP masks with magnets due to potential interference with some implants or certain medical devices.